Back to LBRX
CITADEL ADVISORS LLC LBRX Position History
LB Pharmaceuticals Inc • Healthcare
Quarters held
13
Latest value
$729K
Q3 2026
Peak value
$10M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $8.4M |
| Q3 2025 | $106K |
| Q4 2025 | $9.1M |
| Q1 2026 | $10M |
| Q1 2026 | $276K |
| Q2 2026 | $2.2M |
| Q2 2026 | $4.8M |
| Q2 2026 | $2.2M |
| Q2 2026 | $4.8M |
| Q3 2026 | $1.1M |
| Q3 2026 | $1.1M |
| Q3 2026 | $7.6M |
| Q3 2026 | $729K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $729K | 19.0K | — | — |
| Q3 2026 | $7.6M | 197.7K | — | — |
| Q3 2026 | $1.1M | 28.5K | — | — |
| Q3 2026 | $1.1M | 27.5K | — | — |
| Q2 2026 | $4.8M | 146.7K | — | — |
| Q2 2026 | $2.2M | 69.3K | — | — |
| Q2 2026 | $4.8M | 146.7K | — | — |
| Q2 2026 | $2.2M | 69.3K | — | — |
| Q1 2026 | $276K | 11.2K | — | — |
| Q1 2026 | $10M | 405.7K | — | — |
| Q4 2025 | $9.1M | 407.7K | — | — |
| Q3 2025 | $106K | 6.7K | — | — |
| Q3 2025 | $8.4M | 532.7K | — | — |
Other funds holding LBRX
$128.7M
$108.8M
$82.7M
$74.6M
$53.9M